BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11850480)

  • 1. Comparison of (11)C-choline and (18)F-FDG PET in primary diagnosis and staging of patients with thoracic cancer.
    Pieterman RM; Que TH; Elsinga PH; Pruim J; van Putten JW; Willemsen AT; Vaalburg W; Groen HJ
    J Nucl Med; 2002 Feb; 43(2):167-72. PubMed ID: 11850480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon-11 choline or FDG-PET for staging of oesophageal cancer?
    Jager PL; Que TH; Vaalburg W; Pruim J; Elsinga P; Plukker JT
    Eur J Nucl Med; 2001 Dec; 28(12):1845-9. PubMed ID: 11734925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
    Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
    J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
    Hara T; Inagaki K; Kosaka N; Morita T
    J Nucl Med; 2000 Sep; 41(9):1507-13. PubMed ID: 10994730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
    Khan N; Oriuchi N; Zhang H; Higuchi T; Tian M; Inoue T; Sato N; Endo K
    Nucl Med Commun; 2003 Apr; 24(4):359-66. PubMed ID: 12673163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.
    de Jong IJ; Pruim J; Elsinga PH; Jongen MM; Mensink HJ; Vaalburg W
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1283-8. PubMed ID: 12271408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomographic imaging with 11C-choline in differential diagnosis of head and neck tumors: comparison with 18F-FDG PET.
    Khan N; Oriuchi N; Ninomiya H; Higuchi T; Kamada H; Endo K
    Ann Nucl Med; 2004 Jul; 18(5):409-17. PubMed ID: 15462403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging.
    Kobori O; Kirihara Y; Kosaka N; Hara T
    Cancer; 1999 Nov; 86(9):1638-48. PubMed ID: 10547535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11C-acetate PET imaging of prostate cancer.
    Oyama N; Akino H; Kanamaru H; Suzuki Y; Muramoto S; Yonekura Y; Sadato N; Yamamoto K; Okada K
    J Nucl Med; 2002 Feb; 43(2):181-6. PubMed ID: 11850482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of whole-body (18)F-FDG PET in patients with suspected metastatic brain tumors.
    Jeong HJ; Chung JK; Kim YK; Kim CY; Kim DG; Jeong JM; Lee DS; Jung HW; Lee MC
    J Nucl Med; 2002 Nov; 43(11):1432-7. PubMed ID: 12411544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of prostate cancer with 11C-choline positron emission tomography.
    de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
    Eur Urol; 2002 Jul; 42(1):18-23. PubMed ID: 12121724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
    Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
    J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
    Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
    J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
    Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.